| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MEI Pharma, Inc. | Director | Common Stock | 67,733 | $148,335 | $2.19 | 15 Jul 2025 | Indirect |
| MEI Pharma, Inc. | Director | Common Stock | 4,359 | $9,546 | $2.19 | 15 Jul 2025 | Direct |
| MEI Pharma, Inc. | Director | Stock Option (Right to Buy) | 20,000 | 15 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MEIP | MEI Pharma, Inc. | 15 Jul 2025 | 1 | $0 | 4 | Director | 17 Jul 2025, 21:40 |
| MEIP | MEI Pharma, Inc. | 17 May 2024 | 1 | +$9,827 | 4 | Director | 21 May 2024, 16:00 |
| MEIP | MEI Pharma, Inc. | 18 Dec 2023 | 2 | $0 | 4/A | Director | 12 Jan 2024, 16:00 |
| MEIP | MEI Pharma, Inc. | 18 Dec 2023 | 2 | $0 | 4 | Director | 20 Dec 2023, 21:26 |
| MEIP | MEI Pharma, Inc. | 31 Oct 2023 | 0 | $0 | 3 | Director | 14 Nov 2023, 20:59 |